# DIPK2A

## Overview
DIPK2A is a gene that encodes the divergent protein kinase domain 2A, a protein that plays a pivotal role in various cellular processes, particularly autophagy and mitophagy. As a kinase, DIPK2A is involved in the regulation of autophagosome-lysosome fusion, a critical step in the degradation of cellular components, by interacting with key proteins such as STX17 and VAMP7. This protein is localized to lysosomes and late endosomes, where it facilitates the fusion process essential for maintaining cellular homeostasis (Tian2019DIPK2A). Additionally, DIPK2A is implicated in the regulation of apoptosis, acting as a negative regulator to promote cell survival, and is involved in the regulation of heparan sulfate proteoglycans, which are crucial for cellular uptake processes (Tian2019DIPK2A; Vanderperre2023A). The gene's significance extends to clinical implications, with mutations in DIPK2A being associated with autism spectrum disorders and potentially other cognitive disorders, highlighting its importance in both cellular function and disease (Tian2019DIPK2A).

## Function
The DIPK2A gene encodes a protein that plays a crucial role in cellular processes such as autophagy and mitophagy, which are essential for maintaining cellular homeostasis. DIPK2A is localized on lysosomes and late endosomes, where it promotes the fusion of autophagosomes with lysosomes, a critical step in the autophagic degradation of cellular components. This process is facilitated by DIPK2A's interaction with proteins such as STX17 and VAMP7, which are involved in the autophagosome-lysosome fusion process (Tian2019DIPK2A). The protein also regulates mitophagy by interacting with mitofusin 2 (MFN2), thereby influencing mitochondrial protein levels under mitophagic stimulation (Tian2019DIPK2A).

DIPK2A is involved in the regulation of apoptosis, acting as a negative regulator by inhibiting apoptosis-inducing factors and promoting cell survival. This function is linked to its role in autophagy, as inhibition of autophagy blocks DIPK2A's ability to inhibit apoptosis (Tian2019DIPK2A). Additionally, DIPK2A is associated with the regulation of heparan sulfate proteoglycans, which are crucial for cellular uptake processes, such as the internalization of α-synuclein fibrils (Vanderperre2023A). DIPK2A's involvement in these molecular processes underscores its importance in cellular homeostasis and survival.

## Clinical Significance
Mutations and alterations in the expression of the DIPK2A gene have been implicated in several diseases, particularly autism spectrum disorders (ASDs) and potentially other cognitive disorders. The study by Tian et al. suggests a link between DIPK2A and familial autism, indicating that mutations in this gene may contribute to the pathogenesis of ASDs. However, the precise mechanisms by which DIPK2A mutations lead to these conditions are not fully understood, necessitating further research to elucidate these pathways (Tian2019DIPK2A).

DIPK2A is also involved in the regulation of apoptosis and cell survival, with its overexpression shown to inhibit apoptosis induced by various drugs. This function is mediated through its interactions with STX17 and VAMP7, and disruptions in these interactions could potentially lead to diseases where apoptosis regulation is compromised (Tian2019DIPK2A). The gene's role in autophagy and mitophagy further underscores its importance in maintaining cellular homeostasis, and alterations in these processes could contribute to disease states characterized by impaired autophagy, such as certain neurodegenerative disorders (Tian2019DIPK2A).

## Interactions
DIPK2A, a protein localized to late endosomes and lysosomes, plays a significant role in autophagosome-lysosome fusion by interacting with various SNARE proteins. It binds to VAMP7B, an isoform lacking a SNARE domain, and inhibits its interaction with STX17. This inhibition allows the functional isoform VAMP7A to bind to STX17, promoting the fusion process essential for autophagy (Tian2019DIPK2A). The interaction between DIPK2A and VAMP7B occurs at the C-terminal domain of VAMP7B, while DIPK2A binds to the transmembrane domain of STX17, facilitating the detachment of VAMP7B from STX17 and allowing VAMP7A to occupy the SNARE domain of STX17 (Tian2019DIPK2A).

DIPK2A also interacts with mitochondrial proteins, such as MFN2, indicating a role in mitophagy (Tian2019DIPK2A). Its involvement in cellular protection and proliferation pathways is suggested by its ability to inhibit apoptosis through interactions with STX17 and VAMP7, as DIPK2A overexpression does not inhibit apoptosis in STX17 knockdown cells (Tian2019DIPK2A). These interactions highlight DIPK2A's regulatory role in autophagy and its potential implications for cellular protection and survival.


## References


[1. (Tian2019DIPK2A) Xiaoyu Tian, Pengli Zheng, Chenqian Zhou, Xurui Wang, Hua Ma, Wei Ma, Xiaokai Zhou, Junlin Teng, and Jianguo Chen. Dipk2a promotes stx17- and vamp7-mediated autophagosome-lysosome fusion by binding to vamp7b. Autophagy, 16(5):797–810, July 2019. URL: http://dx.doi.org/10.1080/15548627.2019.1637199, doi:10.1080/15548627.2019.1637199. This article has 34 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1080/15548627.2019.1637199)

2. (Vanderperre2023A) A genome-wide CRISPR/Cas9 screen identifies genes that regulate the cellular uptake of α-synuclein fibrils by modulating heparan sulfate proteoglycans. This article has 1 citations.